Statewide
New Hampshire Bureau of Emergency Medical Services
An undated version is under review. The figures below are from the current listed document.
Drugs and doses55
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Benzodiazepine, Calcium Chloride, Calcium Gluconate, Ceftriaxone10
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 500–1000 mg | PO/PR | not captured | standing | pages 39, 40, 232 |
| Fever | adult | 500–1000 mg | IV | not captured | standing | pages 39, 40, 232 |
| Fever | peds | 15 mg/kg | IV | not captured | standing | pages 39, 40, 232 |
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | pages 59, 62, 232 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | pages 59, 61, 232 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 59, 61, 232 |
| Mild to moderate pain | peds | 15 mg/kg | IV | not captured | standing | pages 59, 62, 232 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | pages 91, 93, 232 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg (max 6 mg) | IV | not captured | standing | pages 91, 93, 232 |
| Wide-complex tachycardia | adult | 6 mg | IV | not captured | standing | pages 92, 93 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | pages 25, 27, 233 |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | pages 25, 27, 233 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 28, 29, 233 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 28, 29, 233 |
| Hyperkalemia | adult | 10–20 mg | NEB | not captured | standing | pages 42, 43, 233 |
| Hyperkalemia | peds | 2.5 mg | NEB | not captured | standing | pages 42, 43, 233 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 85, 87 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 85, 87 |
| VF / pulseless VT | adult | 150 mg | IV/IO | not captured | standing | pages 87, 92, 233 |
| VF / pulseless VT | peds | 5 mg/kg (max 300 mg) | IV/IO | not captured | standing | pages 87, 92, 233 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 79, 80, 233 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | pages 82, 83, 234 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | pages 82, 83, 234 |
| Cardiac arrest | peds | 0.04 mg/kg | IV | not captured | standing | pages 169, 234 |
| Nerve agent exposure | adult | 2 mg | IV/IM | not captured | standing | pages 50, 51, 234 |
| Nerve agent exposure | peds | 0.05–0.1 mg/kg | IV/IM | not captured | standing | pages 50, 51, 234 |
Benzodiazepine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IM/IN | not captured | standing | pages 34, 35, 143, 144 |
| Other | adult | 5 mg | IV | not captured | standing | pages 34, 35, 143, 144 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 34, 35, 143, 144 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 34, 35, 143, 144 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 42, 43 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | pages 42, 43 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | pages 42, 43 |
| Hyperkalemia | peds | 100 mg/kg | IV/IO | not captured | standing | pages 42, 43 |
Ceftriaxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IM | not captured | standing | pages 104, 235 |
| Other | peds | 50 mg/kg | IV/IM | not captured | standing | pages 104, 235 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Droperidol, Epinephrine, Etomidate, Famotidine, Fentanyl10
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 10 mg | IV/IM/PO | not captured | standing | pages 26, 27 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | pages 26, 27 |
| Asthma / bronchospasm | adult | 10 mg | IV/IM/PO | not captured | standing | pages 28, 29 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | pages 28, 29 |
| Croup | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 29 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | peds | 5 mL/kg | IV | not captured | standing | pages 45, 46, 235 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV | not captured | standing | page 32 |
| Nerve agent exposure | adult | 10 mg | IM | not captured | standing | page 50 |
| Nerve agent exposure | adult | 5 mg | IV | not captured | standing | pages 50, 51 |
| Nerve agent exposure | peds | 0.2 mg/kg | IV | not captured | standing | pages 50, 51 |
| Other | adult | 10 mg | IV | not captured | standing | page 34 |
| Other | adult | 5 mg | IV | not captured | standing | pages 34, 35 |
| Other | peds | 0.2 mg/kg | IV | not captured | standing | pages 34, 35 |
| Seizure | adult | 10 mg | IV | not captured | standing | pages 68, 69 |
| Seizure | peds | 0.2 mg/kg | IV | not captured | standing | pages 68, 69 |
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | pages 91, 93 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | pages 91, 93 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV | not captured | standing | pages 91, 236 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IM/PO | not captured | standing | pages 25, 26, 27, 35, 49 |
| Allergic reaction | peds | 1 mg/kg | IV/IM/PO | not captured | standing | pages 25, 26, 27, 35, 49 |
| Dystonic reaction | adult | 25–50 mg | IV/IM | not captured | standing | pages 35, 49 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | pages 35, 49 |
| Other | adult | 25 mg | PO | not captured | standing | page 49 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 1.25 mg | IV/IM | not captured | standing | page 49 |
| Other | adult | 5–10 mg | IV/IM | not captured | standing | page 34 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 25, 27, 238 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 25, 27, 238 |
| Bradycardia | adult | 2–10 mcg | IV | not captured | standing | pages 82, 83, 238 |
| Bradycardia | peds | 0.01 mg/kg | IV | not captured | standing | pages 82, 83, 238 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 84, 85, 86, 87, 238 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 84, 85, 86, 87, 238 |
| Sepsis | peds | 0.05–1 mcg/kg | IV | not captured | standing | pages 70, 71, 238 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV | not captured | standing | pages 186, 239 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 20 mg | IV/IM/PO | not captured | standing | pages 26, 27 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mcg/kg | IV | not captured | standing | pages 117, 187 |
| Other | peds | 0.5–1 mcg/kg | IV | not captured | standing | pages 117, 187 |
| Mild to moderate pain | adult | 25–100 mcg | IV | not captured | standing | pages 59, 62 |
| Mild to moderate pain | adult | 50–100 mcg | IM/IN | not captured | standing | pages 59, 62 |
| Mild to moderate pain | peds | 0.5–1 mcg/kg | IV | not captured | standing | pages 59, 62 |
| Mild to moderate pain | peds | 0.5–1 mcg/kg | IM/IN | not captured | standing | pages 59, 62 |
| RSI induction | adult | 0.5–1 mcg/kg | IV | not captured | standing | pages 117, 187 |
| RSI induction | peds | 0.5–1 mcg/kg | IV | not captured | standing | pages 117, 187 |
G–L Glucagon, Haloperidol, Heparin, Hydrocortisone, Hydromorphone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam13
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 45, 46, 239 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | pages 45, 46, 239 |
| Other | peds | 0.5 mg | IV | not captured | standing | pages 82, 83, 239 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IM | not captured | standing | page 34 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 60 unit/kg | IV | not captured | standing | pages 79, 240 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IM | not captured | standing | pages 24, 240 |
| Adrenal crisis | peds | 2 mg/kg | IV/IM | not captured | standing | pages 24, 240 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5–1 mg | IV | not captured | standing | pages 59, 62, 241 |
| Mild to moderate pain | adult | 1–2 mg | IM | not captured | standing | pages 59, 62, 241 |
| Mild to moderate pain | peds | 0.01–0.02 mg/kg | IV | not captured | standing | pages 59, 62, 241 |
| Mild to moderate pain | peds | 0.01–0.02 mg/kg | IM | not captured | standing | pages 59, 62, 241 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | pages 73, 241 |
| Cyanide poisoning | peds | 70 mg/kg | IV | not captured | standing | pages 73, 241 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 600 mg | PO | not captured | standing | pages 39, 40, 61, 241 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | pages 39, 40, 61, 241 |
| Mild to moderate pain | adult | 400–600 mg | PO | not captured | standing | pages 104, 241 |
| Mild to moderate pain | adult | 600 mg | PO | not captured | standing | pages 59, 61, 241 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | pages 59, 61, 241 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 28, 29 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 28, 29 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 10–20 mg | IV | not captured | standing | pages 82, 83, 242 |
| Bradycardia | adult | 25–50 mg | IM | not captured | standing | pages 82, 242 |
| Bradycardia | peds | 0.1–0.25 mg/kg | IV | not captured | standing | pages 82, 83, 242 |
| Other | adult | 1 mg/kg | IV | not captured | standing | pages 34, 143 |
| Other | adult | 1 mg/kg | IV | not captured | standing | pages 117, 187, 242 |
| Other | adult | 25–50 mg | IM | not captured | standing | pages 118, 242 |
| Other | adult | 25–50 mg | IM | not captured | standing | pages 120, 242 |
| Other | peds | 1 mg/kg | IV | not captured | standing | pages 117, 187, 242 |
| Mild to moderate pain | adult | 10–20 mg | IV | not captured | standing | pages 59, 62, 242 |
| Mild to moderate pain | adult | 25–50 mg | IM/IN | not captured | standing | pages 59, 62, 242 |
| Mild to moderate pain | peds | 0.1–0.25 mg/kg | IV | not captured | standing | pages 59, 62, 242 |
| Mild to moderate pain | peds | 0.5–1 mg/kg | IM/IN | not captured | standing | pages 59, 62, 242 |
| RSI induction | adult | 2 mg/kg | IV | not captured | standing | pages 186, 242 |
| RSI induction | adult | 4 mg/kg | IM | not captured | standing | pages 186, 242 |
| Narrow-complex tachycardia | adult | 10–20 mg | IV | not captured | standing | pages 91, 93, 242 |
| Narrow-complex tachycardia | adult | 25–50 mg | IM | not captured | standing | pages 91, 242 |
| Narrow-complex tachycardia | peds | 0.1–0.25 mg/kg | IV | not captured | standing | pages 91, 93, 242 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IM | not captured | standing | pages 59, 243 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV | not captured | standing | pages 54, 243 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 1 mg/kg | IV/IO | not captured | standing | pages 87, 243 |
| Narrow-complex tachycardia | adult | 1–1.5 mg/kg | IV | not captured | standing | pages 92, 243 |
| Narrow-complex tachycardia | peds | 1 mg/kg | IV | not captured | standing | pages 92, 243 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg | IV | not captured | standing | page 32 |
| Other | adult | 1 mg | IV | not captured | standing | pages 34, 35 |
| Other | adult | 2–4 mg | IV | not captured | standing | page 34 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 34, 35 |
| Seizure | adult | 2–4 mg | IV | not captured | standing | pages 68, 69 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | pages 68, 69 |
| Narrow-complex tachycardia | adult | 1 mg | IV | not captured | standing | pages 91, 93 |
| Narrow-complex tachycardia | peds | 0.05 mg/kg | IV | not captured | standing | pages 91, 93 |
M–O Magnesium Sulfate, Methylprednisolone, Metoclopramide, Metoprolol, Midazolam, Morphine, Naloxone, Nifedipine, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose, Oxytocin13
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 28, 29 |
| Asthma / bronchospasm | peds | 40 mg/kg | IV | not captured | standing | pages 28, 29 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | page 55 |
| Seizure | adult | 4 g | IV | not captured | standing | pages 55, 68 |
| Narrow-complex tachycardia | adult | 1–2 g | IV | not captured | standing | pages 87, 92 |
| Narrow-complex tachycardia | peds | 25–50 mg/kg | IV | not captured | standing | pages 87, 92 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IM | not captured | standing | pages 26, 27 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IM | not captured | standing | pages 26, 27 |
| Asthma / bronchospasm | adult | 125 mg | IV/IM | not captured | standing | pages 28, 29 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IM | not captured | standing | pages 28, 29 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5 mg | IV | not captured | standing | pages 49, 245 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | pages 91, 246 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV | not captured | standing | page 32 |
| Agitation | adult | 5 mg | IM/IN | not captured | standing | page 32 |
| Other | adult | 2.5 mg | IV | not captured | standing | pages 34, 35 |
| Other | adult | 5 mg | IM/IN | not captured | standing | pages 34, 35 |
| Other | adult | 5 mg | IV | not captured | standing | page 34 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 34, 35 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 34, 35 |
| Seizure | adult | 10 mg | IM/IN | not captured | standing | pages 68, 69 |
| Seizure | adult | 5 mg | IV | not captured | standing | pages 68, 69 |
| Seizure | peds | 0.1 mg/kg | IV | not captured | standing | pages 68, 69 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 68, 69 |
| Narrow-complex tachycardia | adult | 2.5 mg | IV | not captured | standing | pages 91, 93 |
| Narrow-complex tachycardia | adult | 5 mg | IM/IN | not captured | standing | pages 91, 93 |
| Narrow-complex tachycardia | peds | 0.05 mg/kg | IV | not captured | standing | pages 91, 93 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 91, 93 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–10 mg | IV/IM | not captured | standing | page 203 |
| Mild to moderate pain | adult | 2–10 mg | IV/IM | not captured | standing | pages 59, 62, 248 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IM | not captured | standing | pages 59, 62, 248 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IM | not captured | standing | pages 57, 58, 248 |
| Opioid overdose | adult | 0.4–2 mg | IV | not captured | standing | pages 57, 58, 248 |
| Opioid overdose | adult | 2 mg | IN | not captured | standing | pages 57, 58, 248 |
| Opioid overdose | peds | 0.1 mg/kg | IM | not captured | standing | pages 57, 58, 248 |
| Opioid overdose | peds | 0.1 mg/kg | IV | not captured | standing | pages 57, 58, 248 |
| Opioid overdose | peds | 1 mg | IN | not captured | standing | pages 57, 58, 248 |
Nifedipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | PO | not captured | standing | pages 3, 54 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 79, 249 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 89, 249 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 1–15 mcg | IV | not captured | standing | pages 72, 250 |
| Hypotension / shock | peds | 0.05 mcg/kg | IV | not captured | standing | pages 90, 250 |
| Sepsis | adult | 1–15 mcg | IV | not captured | standing | pages 70, 71, 250 |
| Sepsis | peds | 0.05 mcg/kg | IV | not captured | standing | pages 70, 71, 250 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM/PO | not captured | standing | pages 49, 250 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM/PO | not captured | standing | pages 49, 250 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–30 g | PO | not captured | standing | pages 45, 46, 240 |
| Hypoglycemia | peds | 15–30 g | PO | not captured | standing | pages 45, 46, 240 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | pages 38, 54, 250 |
P–R Pralidoxime, Prednisone, Prochlorperazine, Proparacaine, Rocuronium5
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1–2 g | IV | not captured | standing | pages 50, 51, 250 |
| Nerve agent exposure | peds | 20–50 mg/kg | IV | not captured | standing | pages 50, 51, 250 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 60 mg | PO | not captured | standing | pages 26, 251 |
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5 mg | IV/IM | not captured | standing | pages 49, 251 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | TOP/OPH | not captured | standing | pages 91, 101, 253, 254, 255 |
| Other | peds | 2 drop | TOP/OPH | not captured | standing | pages 91, 101, 253, 254, 255 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV | not captured | standing | pages 186, 251 |
S–Z Sodium Bicarbonate, Succinylcholine, Tetracaine, Tranexamic Acid4
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 42, 43, 87, 251 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 42, 43, 87, 251 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 98, 99, 251 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 98, 99, 251 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 64, 66, 251 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 64, 66, 251 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV | not captured | standing | pages 186, 252 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | TOP/OPH | not captured | standing | pages 101, 253, 254, 255 |
| Other | peds | 2 drop | TOP/OPH | not captured | standing | pages 101, 253, 254, 255 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 g | IV/IO | not captured | standing | page 25 |
| Obstetric hemorrhage | adult | 1 g | IV/IO | not captured | standing | pages 38, 54 |
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 102 |
Cite this
New Hampshire Bureau of Emergency Medical Services, United States EMS Protocol Census. 195 dose entries, effective 2025-11-07.
https://protoquiz.com/census/agencies/new-hampshire-bureau-of-emergency-medical-services/
The census is free and not for sale. Only public agencies are named.